after mobilization grow quickly and create a Covid-19 vaccine, Johnson & Johnson is excessive reduce your efforts in the production of shots as it is facing a demand slowdown.
The New Brunswick, NJ, pharmaceutical company in recent months terminated manufacturing agreements with companies that helped produce the shot during the pandemic such as catalant Inc and sanofi Like